Onebode - FLO
Onebode - FLO, licence 80039118: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- OneBode Holdings, LLC
- NPN or DIN-HM
- 80039118
- Status
- Active licence
- Licence date
- 28 January 2013
- Revision date
- Not provided
- Form
- Capsule végétale
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase bactérien Source : Bacillus subtilis - cellule entière Potency : 3000.0 FCC PC | 3.0 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 15750.0 FCC HUT | 59.0 mg | Not calculated |
| Diastase du malt Source : Aspergillus flavus var. oryzae - En entier Potency : 75.0 FCC DP | 2.3 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens Potency : 500.0 FCC SU | 15.0 mg | Not calculated |
| Zingiber officinale Source : Rhizome | 10.0 mg | Not calculated |
Non-medicinal ingredients
rouge de betterave, Stéarate de magnésium, Mélasse, Hypromellose, Aqua
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Capsule ; maximum: 3.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides live microorganisms that temporarily modify gut flora. Probiotics that temporarily modify gut flora. Source of probiotics. A digestive aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039118
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.